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CC BY-NC-ND license (http://creativeAbstract Epithelial-mesenchymal transition (EMT) is the phenotypic transition of epithelial
cells to mesenchymal cells characterized by loss of epithelial markers, loss of intercellular
adherence and acquirement of mesenchymal cell markers and increased locomotive ability.
EMT is widely considered to be a gene regulated process necessary for cancer metastasis.
Yet it is a highly controversial issue. We here propose that EMT is an environmentally induced
cell behavior. It is the mimicry of their living environment. It is a survival strategy, a way of
immune escape. We also propose here that the epithelial cell markers may functionally act
as tumor antigens since in the mesenchymal surroundings there are no other structures bearing
the same antigens as epithelial cells.
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by-nc-nd/4.0/).Introduction
Epithelial-mesenchymal transition (EMT), originally a term
in embryology describing the process of mesoderm forma-
tion and extension from the epithelial ectoderm, has been
a hot spot of cancer research for its supposed roles in the
process of cancer progression and metastasis for the past
decade. There are a few hallmarks of EMT, including loss of
epithelial cell polarity, loss expression of epithelial cell
membrane markers such as E-cadherin and p120-catenin,
and the acquired expression of mesenchymal cell marker
vimentin. This phenotypical change of epithelial carcinoma
cells is widely considered to be an essential step for cancer
metastasis. However, there remains a fierce disagreementity of Chongqing Medical
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16.10.001
ng Medical University. Production
commons.org/licenses/by-nc-nd/on the genuine existence and the role of EMT, and its role in
cancer metastasis.1 We here propose a new explanation for
the role of EMT, by focusing its biological significance in
cancer cell survival.
Controversies
Although publications on the role of EMT in cancer metas-
tasis have been increasing rapidly, there exist intense de-
bates on the existence of EMT and the supposed role of EMT
in cancer metastasis.1 At first, some pathologists doubt the
real existence of EMT.1e3 The pathological picture of EMT
somewhat depends on who is to explain it. Serious pathol-
ogist like Dr. Tarin of California University denied the
concept of EMT, even in the embryonic development.2 The
second aspect of the controversies is the paradoxes of EMT
phenomena with clinical outcomes.ymal transition as strategic microenvironment mimicry for cancer
.doi.org/10.1016/j.gendis.2016.10.001
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+ MODELIn the breast pathology, there is a lesion termed lobular
tumor, which includes lobular carcinoma in situ (LCIS), and
invasive lobular carcinoma (ILC). Both the lesions are char-
acterized by the loss of E-cadherin expression, and the loose
connection between the tumor cells. However, when simple
LCIS is pathologically diagnosed, clinicians would not take
treatmentprocedures if no further signs ofmalignancieswere
found.4 Clinical studies have long established that most LCIS
did not develop further.4 This fact clearly does not support
the notion of in situ carcinoma cells first go through EMT, then
degrade the basement membrane by secreting matrix met-
alloproteinase (MMP), and evolve to invasive carcinoma.5
Moreover, in spite of negative E-cadherin expression, the
invasive lobular carcinoma of breast do not show a worse
clinical outcome as comparing with the invasive ductal car-
cinoma, which is the most popular histological type of breast
cancer and retains E-cadherin expression. Indeed, the signet
ring cell gastric cancer is without E-cadherin expression, and
extremely poor clinical outcomes.6 For the reverse, Chu et al
found that in invasive breast cancer the overexpression of E-
cadherin is associated with decreased relapse-free survival.7
At a big vision, the level of E-cadherin expression has notbeen
found to be clinically significant for the prognosis of cancer
patients in most types of cancer.
Paradoxes of EMT also extend to cultured cell lines. A
highly metastatic mouse breast cancer cell line, 4T1, has a
high level of E-cadherin expression.7 In our experience,
these cells adhere very tightly with each other, and to the
culture plate. They are very difficult to digest, hard to
disperse by enzyme or by pipetting. Therefore, intercel-
lular tight connection is not a barrier to metastasis. In other
words, EMT is not essential for metastasis. Notably, a
recent study published in Nature clearly showed that EMT
was not required for lung metastasis of breast cancer, but
contributed to chemoresistance.8
More evidence come from the fact that desmoglein 3,
one of the desmosomal cadherins which mediate cellecell
adhesion in desmosome, has an increased expression in a
variety of cancers.9 This fact also contradicts the notion of
EMT in cancer metastasis.
New vision on the biology of EMT
We here suggest a novel biological role of EMT in cancer. To
understand EMT, we need to compare the living environ-
ment of normal epithelial cells with that of the invasive
cancer cells, which is by nature epithelial cells. The normal
epithelium is separated from the mesenchymal tissue by a
thin, yet very important structure, the basement mem-
brane. As a result, the normal epithelial cells are in a
special environment in which there are no blood vessels or
lymphatics. While the carcinoma cells are epithelial cells in
mesenchyme without protection of intact basement mem-
brane. They are cells displaced to the wrong mesenchymal
territory.5 A critical question which perplexes immunolo-
gists is that if the epithelial cells were put into the
mesenchymal tissue, would immunoreactions be provoked?
The immediate response of immunologists to this ques-
tion would be no. But soon he/she would admit that there is
no answer to it yet. By the clonal selection theory of
Burnet, all the lymphocyte clones which respond to self-Please cite this article in press as: Qin J-H, et al., Epithelial-mesench
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opment.10 However, by logic we cannot refute a reasonable
hypothesis by an established theory, because any theory in
nature is hypothesis with uncertainty. In fact, the clonal
selection theory has been facing serious challenges for
many years.11 For example, if all the self-recognizing
lymphocyte clones were eliminated, how did the self-
antibodies were produced in patients with autoimmune
diseases?12
Another paradoxical question is the identity of tumor
antigen. So far there are no tumor specific antigens iden-
tified for most types of cancer. Yet undoubtedly, the or-
ganism exerts immune reaction against cancer. This raise
the question of what antigens are these immune reactions
targeting at?
Now we come back to the invasive cancer. By nature,
the invasive cancer cells are epithelial cells dispersed in
mesenchymal tissue. There is no surrounding basement
membrane to protect them. They are facing the immune
cells directly. In parable, the normal epithelium is zoo, or
city, while the mesenchymal microenvironment is jungle.
They are facing a variety of stresses,13 of which one is im-
mune stress. They have to find ways to increase their sur-
vival chances. It will be helpful to take a look at what those
creatures do in the jungle.
A universal phenotypic behavior of all the creatures is
not to stand out from the surroundings, but to keep as
closely similar as possible to their surroundings. The term
for this phenomena is mimicry, or camouflage. The pepper
moth and grass hoppers wear different colors and graphic
patterns in different surroundings. That makes them less
vulnerable to the predators. The polar bears are white
because it gives them more chance to successively hunt.
Now here is the case of cancer cells with epithelial
markers in the mesenchymal tissue. Obviously they are in-
vaders in a surrounding of no other structures which bear
epithelial markers. These invaders are to bring damage to
the organism. They constitute danger.14 By the danger
model of immune reaction proposed by Matzinger,15 the
immune cells will try to destroy these invading epithelial
cells.14,15 Whatever the reason is, the immune system
needs to eliminate the invaded epithelial cells to keep the
normal structure of the body. Their target could be nothing
but the epithelial markers on the cell membrane of these
cancer cells, if there were no new antigens emerge from
gene mutations.
Then a natural choice for the cancer cells is to lower the
level of epithelial cell marker expression, such as that of E-
cadherin. This would be especially the strategy for those of
the dispersed single, or small clusters of cancer cells, and
those at the periphery of cancer tissue. Interestingly, this
corresponds to the hallmark of EMT. Therefore, EMT is a
strategy of immune escape adopted by cancer cells to in-
crease their chances of survival in mesenchymal tissues, by
mimicry. Alternatively, the misplaced epithelial cells may
really transform to mesenchymal cells. They not only lose
the expression of epithelial markers, but also acquire the
expression of vimentin, a mesenchymal cell marker, and
morphologically take the shape of mesenchymal cells. In
such a case, it would be hard to identify them, not only by
immune cells, but also by pathologists, by cancer scientists.ymal transition as strategic microenvironment mimicry for cancer
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seen in cancer stromal cells.16
However, for a large cancer mass, lowering the epithe-
lial marker expression is not the only way of protecting
themselves. The cancer cells would strengthen their
intercellular connections to prevent infiltration of immune
cells.9 In analogy, when an army was in action, it would
take effective measures to strengthen their connection to
prevent infiltration attempts from the enemy. Otherwise it
would be a disaster. Therefore, the decreased expression of
epithelial markers in dispersed cancer cells and the
strengthened intercellular connection characterized by up-
regulation of desmoglein proteins are both survival strate-
gies of cancer cells.
Conclusion
Carcinoma cells are epithelial cells malignantly trans-
formed in the wrong, mesenchymal microenvironment.
Their epithelial markers make them stand out from the
mesenchymal surroundings and easily become the targets
of immune cells. Consequently, the cancer cells take the
strategy of mimicry to lower its identity by simulation of
their surroundings, which is a practical approach of immune
escape. Therefore, EMT is a basic survival strategy adopted
by cancer cells in the stressful environment. Although
metastasis is also a stress response of cancer cells,13,17 EMT
may not be an essential process for cancer metastasis.8 An
important issue raised in this paper is the identity of cancer
antigens and the possibility of epithelial cell markers as
working antigen in cancer immunity. Elucidation of this
basic question will help understanding the biology of cancer
and the role of immunity in cancer progression, which is a
typical double-edged sword. By one of the edge, immunity
checks the development of cancer by killing cancer cells;
by the other edge, immunity facilitates cancer progression
by inflammation. Interestingly, the paradoxical, these
opposite effects of immunity in cancer are widely accepted
by cancer researchers, which is a so-called antinomy by
Immanuel Kant.
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